Navigation Links
G-CON Manufacturing Announces that it has Received a Notice of Allowance for its Modular, Self-Contained Mobile Clean Room Patent Application
Date:11/8/2016

G-CON today announced that it has received a Notice of Allowance from the United States Patent and Trademark Office for its Patent Application 12/856,888 entitled Modular, Self-Contained, Mobile Clean Room. G-CON was founded on this proprietary platform approach that transforms the way that cleanrooms are designed and built. G-CON’s in-house engineering team designs the PODs to meet the customer’s specifications followed by the PODs being built and qualified entirely in G-CON’s facilities. G-CON was the first to invent and offer this novel turnkey approach of delivering prefabricated cleanrooms, which are generally built in place and are provided as construction projects with attendant delays and unpredictable costs. The G-CON POD approach allows for a much more predictable result in terms of costs, schedule and quality since the same team builds each POD with the same core materials thereby avoiding product variability due to changing raw materials and transient construction crews.

The U.S. Patent and Trademark’s Notice of Allowance validates the G-CON platform as a novel way to produce cleanrooms. Such a finding is the latest endorsement of the cleanroom POD approach with G-CON having won several awards for product innovation in the pharmaceutical and biopharmaceutical industry including but not limited to: The ISPE’s Faciltiy of the Year Award for Equipment Innovation 2016, Interphex’s Best Technology Innovation 2015, Pharmaceutical Processing’s Facility of the Year, and a Finalist in the category for Best Collaboration Partnerships for the 2016 BioProcess International Awards.

Maik Jornitz, President and CEO of G-CON Manufacturing stated: “We are delighted to receive the Notice of Allowance from the U.S. Patent and Trademark Office. Such a Notice further validates our innovative POD approach. It motivates us to develop other cleanroom platforms, as well as unique facility concepts with our partners. When we started in 2009 we had one product for one application. Our product portfolio now includes a much larger variety of standard PODs, which can be configured to the needs of our customers. The current POD range meets the requirements of a number of applications, including bioprocessing, oral solid dosage forms, predesigned filling and single-use technology unit operations and the strict containment needs for ADCs and cell therapies. This notice and ultimately the patent strengthens our position of being the most advanced and largest prefabricated cleanroom provider globally.”

About G-CON Manufacturing
G-CON Manufacturing designs, builds and installs prefabricated, autonomous cleanroom PODs®. G-CON’s cleanroom POD® portfolio provides a number of dimensions for a variety of uses, from laboratory environments to personalized medicine and production process platforms. The POD® cleanroom units surpass traditional cleanroom structures by virtue of their scalability, mobility and the possibility of repurposing the PODs® once the production process reaches its lifecycle end. For more information, please visit the G-CON’s website at http://www.gconbio.com.

Read the full story at http://www.prweb.com/releases/gcon/patent/prweb13828146.htm.


'/>"/>
Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved


Related medicine news :

1. Former FDA Official to Conduct ComplianceOnline Seminar on Manufacturing and Marketing Cosmeceutical and Homeopathic OTCs
2. Pharma Contract Manufacturing: World Market Outlook 2013-2023
3. Enduro Expands with New Manufacturing Facility and Products
4. Prescription Acne Treatment Manufacturing in the US Industry Market Research Report from IBISWorld Has Been Updated
5. Medical Instrument and Supply Manufacturing the US Industry Market Research Report from IBISWorld Has Been Updated
6. Cosmetic & Beauty Products Manufacturing in the US Industry Market Research Report from IBISWorld Has Been Updated
7. Global Pharmaceuticals & Medicine Manufacturing Industry Market Research Report from IBISWorld has Been Updated
8. Global Pharmaceutical Contract Manufacturing Market
9. Activated Carbon Manufacturing in the US Industry Market Research Report Now Available from IBISWorld
10. Key Joy West Expands their Business from Custom Cable Assembly to Custom Contract Manufacturing
11. Light fantastic -- Cable announces £3.6 million for manufacturing research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2017)... ... August 18, 2017 , ... ... a transparent, verifiable database to help the cannabis industry move towards greater legitimacy. ... to deliver a faster technology with lower fees. Paragon will build a fully ...
(Date:8/19/2017)... ... August 19, 2017 , ... Yesterday, the President of the ... there are two sides. There are not two sides to hatred, bigotry, discrimination, and ... and prejudice, and the NPEIV stands against all forms of such hatred and discrimination ...
(Date:8/18/2017)... , ... August 18, 2017 , ... More than 20,000 ... Republic of Congo (DRC) thanks to an ambitious venture that conjoined the passions of ... the generous support of the Liberty community. These shoes will save lives from the ...
(Date:8/18/2017)... ... 18, 2017 , ... Mediaplanet today announces the launch of ... and highlighting the importance of proactive eye and ear health. The campaign focuses ... innovations in hearing aid technology. , In this issue, the American Speech-Language-Hearing ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... services to communities in east Texas, is launching a regional charity effort to ... Founded in 1991, the Pediatric Brain Tumor Foundation (PBTF) has raised nearly $30 ...
Breaking Medicine News(10 mins):
(Date:8/17/2017)... , Aug. 17, 2017 Bio-Ess Laboratories, LLC Chief Science ... antibody titer and present new data on Cell-Ess® Universal Titer ... Boston, MA August 21-25.  The Bioprocessing Summit convenes ... bioprocess challenges. ... Optimizer ...
(Date:8/15/2017)... OCEANSIDE, Calif. , Aug. 15, 2017  AOTI Inc. announced ... Advanced Oxygen Therapy Inc., has recently opened a New York City ... the ever-increasing usage of its unique Topical Wound Oxygen (TWO 2 ... approved by the Accreditation Commission for Health Care (ACHC) under the ... ...
(Date:8/8/2017)... 2017   Second-quarter ... (GAAP) loss per share from continuing operations ... increased 16 percent to $110 million ... percent to $161 million ... continuing operations increased 8 percent to $0.93 ...
Breaking Medicine Technology: